Vaxil Bio Ltd. (TSXV:VXL)
Canada · Delayed Price · Currency is CAD 0.1500
0.00 (0.00%)
At close: Apr 1, 2026
Vaxil Bio Market Cap
Vaxil Bio has a market cap or net worth of CAD 597.6 thousand as of April 13, 2026. Its market cap has decreased by -78.19% in one year.
Market Cap
597.60K
Enterprise Value
150.60K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since March 10, 2016, Vaxil Bio's market cap has increased from 97.36K to 597.60K, an increase of 513.83%. That is a compound annual growth rate of 19.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 597.60K | 3.45% |
| Dec 30, 2025 | 577.68K | -83.13% |
| Dec 29, 2023 | 3.42M | 25.00% |
| Dec 30, 2022 | 2.74M | -73.33% |
| Dec 31, 2021 | 10.27M | -70.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytophage Technologies | 2.71M |
| BioVaxys Technology | 2.43M |
| Rakovina Therapeutics | 2.01M |
| Appili Therapeutics | 1.99M |
| Universal Ibogaine | 1.56M |
| Entheon Biomedical | 1.39M |
| Waverley Pharma | 540.00K |
| ChitogenX | 415.65K |